Stay updated on GLPG2737 in Combination With Orkambi Clinical Trial
Sign up to get notified when there's something new on the GLPG2737 in Combination With Orkambi Clinical Trial page.

Latest updates to the GLPG2737 in Combination With Orkambi Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe page revision label was updated to v3.6.3, indicating a newer release of the page template/content; this does not appear to change the study details.SummaryDifference0.1%

- Check20 days agoChange DetectedThe page’s revision label was updated from v3.6.0 to v3.6.2, indicating a small update to the page’s version metadata.SummaryDifference0.1%

- Check34 days agoChange DetectedNew sections for reading a study record, common questions, and how to join a study appear, and recruitment now indicates no participants are being sought; the Intervention/Treatment heading formatting has changed from 'Intervention / Treatment' to 'Intervention/Treatment'.SummaryDifference0.5%

- Check41 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, signaling a newer revision of the study record's metadata. This reflects a metadata update rather than a change to the substantive study content.SummaryDifference0.1%

- Check55 days agoChange DetectedThe sponsor field on the study record changed from Galapagos NV to Lakefront Biotherapeutics NV, reflecting a sponsor transition for the GLPG2737-CL-202 trial. This updates who is responsible for the study’s oversight and communications.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page now shows revision: v3.5.4 replacing the previous v3.5.3, indicating a recent metadata/maintenance update rather than a substantive change to study content.SummaryDifference0.1%

Stay in the know with updates to GLPG2737 in Combination With Orkambi Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GLPG2737 in Combination With Orkambi Clinical Trial page.